All News

CURE® spoke with CEO Linda Tantawi about addressing the needs of underserved communities and how education is key in helping women in the Greater New York City area.

The Food and Drug Administration granted a priority review to Bavencio (avelumab) in combination with Inlyta (axitinib) to treat patients with advanced renal cell carcinoma (RCC).

Imbruvica (ibrutinib) may be superior to standard of care in elderly patients with untreated chronic lymphocytic leukemia (CLL), according to phase 3 findings published in the New England Journal of Medicine.

The emotional ups and downs associated with a diagnosis of breast cancer can take a person on a very stressful ride. In this post, learn how one survivor managed to turn that stressful event into a joy ride.

A five-year lesson in cancer, worry and hope.

The Food and Drug Administration granted a priority review to the supplemental biologics license application for Keytruda (pembrolizumab) for the first-line treatment of patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC).

Cancer survivors struggle to sort out "normal" signs of aging from symptoms of cancer's return.

Why it matters when hope isn't really hope at all (and tips on reading articles about cancer research).

A preclinical study showed that FGL2 protein suppression may stop tumor cell growth in patients with glioblastoma.

Check out this week’s quick overview of what is making headlines in the cancer space.

Survivors with children face some of the biggest challenges when it comes to visualizing the future. After my breast cancer diagnosis in 1986, it was my daughter's future, rather than my own, for which I bargained.

The Cholangiocarcinoma Foundation has won a grant from Bayer to create a website and outreach to patients and doctors to let them know that all patients with the disease need to have their tumors sequenced, because there are existing medicines and clinical trials that may help patients with actionable mutations more than the standard of care.

I am the first to admit that I have a love-hate relationship with breast forms post-mastectomy. Every now and then, I do put one on. It comforts me to know that there are multiple options (especially for women who wear them regularly).

I've had many outward signs that let the world know I had cancer, so the latest addition to my wardrobe didn't exactly make it much more obvious.

Obesity may be to blame for increasing rates of certain cancers in young adults.

Here are tips for fellow cancer survivors to clear out cancer paraphernailia but keep important medical records.

Targeted drugs and immunotherapies are still on the horizon for people with cholangiocarcinoma, or bile duct cancer.

I feel fortunate to have my disease in this time of accelerated innovation

President Donald J. Trump announced his plan to amp up the fight against childhood cancer, and to lower prescription drug costs.

Ian W. Flinn, M.D., Ph.D., discusses the use of Copiktra, which was approved in September for patients with relapsed/refractory chronic lymphocytic leukemia.

After two bouts of cancer, happiness is a warm tush.

I had no idea learning to sit with people in their pain would help me learn how to deal with my own.

Splitting up Darzalex dosing had comparable results to standard dosing schedules in patients with myeloma.

One CURE contributor shares her hopes - and doubts - about recent cancer news.

If we are honest, I think most of us wonder deep down if we are going to live long enough to see the next grandchild, attend an important wedding or anniversary, or finish a project.

Researchers are evaluating the use of folate receptors to treat platinum-resistant ovarian cancer.

What can cancer centers boast that they do better than another?